enoxacin has been researched along with Acute Bacterial Prostatitis in 7 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks." | 9.14 | [Enoxacin for type III A prostatitis: a clinical observation]. ( Chen, Z; Chen, ZQ; Deng, RJ; Ye, ZQ; Zhou, XC, 2010) |
| "The clinical efficacy of enoxacin (ENX) was evaluated in 39 patients having chronic prostatitis." | 7.67 | [The therapeutic effect of enoxacin on chronic prostatitis]. ( Katsumi, T; Murayama, K, 1989) |
| "Ten patients with prostatitis were administered with Enoxacin (ENX), and the changes in its concentration in the seminal fluid were studied." | 7.67 | [Enoxacin in the seminal fluid of prostatitis patients]. ( Asakawa, M; Yasumoto, R, 1988) |
| "To examine the diffusion of enoxacin into the prostatic fluid of patients with chronic prostatitis, the serum level and the expressed prostatic secretion (EPS) level of enoxacin were measured." | 7.67 | [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient]. ( Hirabayashi, S; Nakano, Y; Ono, Y; Tanaka, K; Yamada, S, 1988) |
| "Enoxacin was administered at the daily dosage of 400 mg every 12 hours for 10 days starting from the enrollment." | 6.66 | [Enoxacin in the treatment of bacterial prostato-cystitis]. ( Austoni, E; Dal Prà, ML; Mandressi, A; Mantovani, F; Mascheroni, E; Montanari, E; Pisani, E, 1989) |
| "We selected 198 cases of III A prostatitis with complete treatment and follow-up data from the outpatients, all treated by enoxacin injection for 1 week, followed by oral medication of enoxacin for 2 weeks." | 5.14 | [Enoxacin for type III A prostatitis: a clinical observation]. ( Chen, Z; Chen, ZQ; Deng, RJ; Ye, ZQ; Zhou, XC, 2010) |
| "The clinical efficacy of enoxacin (ENX) was evaluated in 39 patients having chronic prostatitis." | 3.67 | [The therapeutic effect of enoxacin on chronic prostatitis]. ( Katsumi, T; Murayama, K, 1989) |
| "Ten patients with prostatitis were administered with Enoxacin (ENX), and the changes in its concentration in the seminal fluid were studied." | 3.67 | [Enoxacin in the seminal fluid of prostatitis patients]. ( Asakawa, M; Yasumoto, R, 1988) |
| "To examine the diffusion of enoxacin into the prostatic fluid of patients with chronic prostatitis, the serum level and the expressed prostatic secretion (EPS) level of enoxacin were measured." | 3.67 | [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient]. ( Hirabayashi, S; Nakano, Y; Ono, Y; Tanaka, K; Yamada, S, 1988) |
| "Enoxacin was administered at the daily dosage of 400 mg every 12 hours for 10 days starting from the enrollment." | 2.66 | [Enoxacin in the treatment of bacterial prostato-cystitis]. ( Austoni, E; Dal Prà, ML; Mandressi, A; Mantovani, F; Mascheroni, E; Montanari, E; Pisani, E, 1989) |
| "Enoxacin treatment was efficacious in 89." | 1.28 | [Treatment of male genital infections with enoxacin]. ( Andreini, F; Bartelloni, M; Campa, M; Canale, D; Di Coscio, M; Giorgi, P; Giorgi, PM; Meschini, P; Poggi, MS; Turchi, P, 1989) |
| " AT-2266 was administered in a daily dosage of 600 mg (in 3 divided doses) for 14 days." | 1.27 | [Therapeutic studies on chronic prostatitis--use of AT-2266--Sapporo Clinical Research Group for STD]. ( Gohro, T; Henmi, I; Inoke, T; Kato, S; Kumamoto, Y; Saka, T; Sakai, S; Tabata, S; Tamate, H; Tanda, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Zhou, XC | 1 |
| Chen, ZQ | 1 |
| Ye, ZQ | 1 |
| Deng, RJ | 1 |
| Giorgi, PM | 1 |
| Giorgi, P | 1 |
| Canale, D | 1 |
| Turchi, P | 1 |
| Poggi, MS | 1 |
| Di Coscio, M | 1 |
| Bartelloni, M | 1 |
| Meschini, P | 1 |
| Andreini, F | 1 |
| Campa, M | 1 |
| Mantovani, F | 1 |
| Mascheroni, E | 1 |
| Dal Prà, ML | 1 |
| Montanari, E | 1 |
| Mandressi, A | 1 |
| Austoni, E | 1 |
| Pisani, E | 1 |
| Katsumi, T | 1 |
| Murayama, K | 1 |
| Yasumoto, R | 1 |
| Asakawa, M | 1 |
| Tanaka, K | 1 |
| Nakano, Y | 1 |
| Ono, Y | 1 |
| Hirabayashi, S | 1 |
| Yamada, S | 1 |
| Kumamoto, Y | 1 |
| Sakai, S | 1 |
| Tamate, H | 1 |
| Gohro, T | 1 |
| Inoke, T | 1 |
| Tabata, S | 1 |
| Tanda, H | 1 |
| Kato, S | 1 |
| Saka, T | 1 |
| Henmi, I | 1 |
2 trials available for enoxacin and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
[Enoxacin for type III A prostatitis: a clinical observation].
Topics: Adult; Anti-Infective Agents; Chronic Disease; Enoxacin; Humans; Male; Middle Aged; Prostatitis; Tre | 2010 |
[Enoxacin in the treatment of bacterial prostato-cystitis].
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Chronic Disease; Clinical Trials as Topic; Cystiti | 1989 |
5 other studies available for enoxacin and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
[Treatment of male genital infections with enoxacin].
Topics: Adult; Bacterial Infections; Cystitis; Enoxacin; Humans; Infertility, Male; Male; Middle Aged; Prost | 1989 |
[The therapeutic effect of enoxacin on chronic prostatitis].
Topics: Adult; Chronic Disease; Drug Evaluation; Enoxacin; Humans; Male; Middle Aged; Prostatitis | 1989 |
[Enoxacin in the seminal fluid of prostatitis patients].
Topics: Adolescent; Adult; Enoxacin; Humans; Male; Middle Aged; Prostatitis; Semen | 1988 |
[The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
Topics: Adult; Aged; Body Fluids; Chronic Disease; Diffusion; Enoxacin; Humans; Male; Middle Aged; Prostate; | 1988 |
[Therapeutic studies on chronic prostatitis--use of AT-2266--Sapporo Clinical Research Group for STD].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Drug Administration Schedule; Enoxacin; Humans; | 1986 |